Amerisource Bergen Corp.

Amerisource Bergen Corp.

ABC

Market Cap$36.15B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Amerisource Bergen Corp.Amerisource Bergen Corp.39.30.57%192%0.15.9

Earnings Call Q2 2025

May 7, 2025 - AI Summary

Strong Financial Performance: Cencora reported a 10% revenue growth ($75.5 billion) and a 16% growth in adjusted diluted EPS for Q2 FY2025. The company is raising its full-year guidance for adjusted operating income and adjusted diluted EPS based on these results, now forecasting EPS between $15.70 to $15.95, up from $15.30 to $15.60.
Focus on Specialty Market: The company is well-positioned in the growing specialty medications market, with growth driven by new product introductions and deepening partnerships with healthcare providers. Sales of GLP-1 products increased significantly, although there's a noted sequential decline indicating potential future challenges.
International Segment Challenges: Cencora's International Healthcare Solutions segment forecast was downgraded due to subdued clinical trial activity, impacting specialty logistics. Operating income expectations for this segment are now projected to decline slightly (down 4% to down 1%).

Exclusive for Stockcircle Pro members

Sign upSign Up
$192.20

Current Fair Value

6.8% upside

Undervalued by 6.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$36.15 Billion
Enterprise Value$37.70 Billion
Dividend Yield$1.94 (0.568904593639576%)
Earnings per Share$8.53
Beta0.56
Outstanding Shares201,837,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio39.27
PEG-40.13
Price to Sales0.12
Price to Book Ratio59.99
Enterprise Value to Revenue0.13
Enterprise Value to EBIT15.21
Enterprise Value to Net Income24
Total Debt to Enterprise0.12
Debt to Equity5.95

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Amerisource Bergen Corp.

22,000 employees
CEO: Steven Collis

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their part...